Skip to main content

KPCB XVI Associates, LLC

SEC CIK
0001611734
Latest filing
Oct 25, 2021

The latest 13F from KPCB XVI Associates, LLC covers Q3 2021 (filed Oct 25, 2021): 3 long positions worth $224.6M. The top 10 holdings make up 100.0% of the portfolio, and the largest is Desktop Metal, Inc. (DM) at 55.9%. Livermore has 3 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q3 2021

Share counts compared with Q2 2021: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
1
Est. +$75.8M
Added
0
Reduced
0
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. DMDesktop Metal, Inc.
    55.9%$125.4MHistory
  2. LIDRAEye, Inc.
    33.8%$75.8MHistory
  3. VERAVera Therapeutics, Inc.
    10.4%$23.3MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. LIDRAEye, Inc.
    +$75.8MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. LIDRAEye, Inc.
    +33.77 pp0.0% → 33.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

None this quarter.

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

None this quarter.

Metrics

13F metrics for Q3 2021, computed only from the numbers in the filings. Definitions below.

Portfolio value
$224.6M
+$7.35M (+3.4%) vs. prior quarter
Positions
3
+1 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
0.0%
Q3 2021, one quarter
Average holding period
2.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

3 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $237.6M (Q1 2021)

Q1 2021: $237.6MQ2 2021: $217.2MQ3 2021: $224.6M
Q1 2021Q3 2021
13F filings of KPCB XVI Associates, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2021Oct 25, 20213$224.6MDMLIDRVERAvs. Q2 2021SEC
Q2 2021Jul 28, 20212$217.2MDMVERAvs. Q1 2021SEC
Q1 2021May 13, 20211$237.6MDM–SEC

13D and 13G filings

Companies where KPCB XVI Associates, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

KPCB XVI Associates, LLC does not currently report owning 5% or more of any company.

Latest filings

1 filing on file made by KPCB XVI Associates, LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by KPCB XVI Associates, LLC
CompanyFiled (ET)FilerFormStakeChangeEvent dateFiling
AMBQAmbiq Micro, Inc.Nov 3, 20259:50 PM ETKleiner Perkins Caufield & Byers XVI, LLCand 5 others13G8.20%1.49M sharesNewSep 30, 2025SEC